Adagene Inc. ADR is a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibody-based cancer immunotherapies. The company develops a platform of proprietary antibody technologies designed to improve the precision, safety, and effectiveness of biologic medicines, with current work centered on oncology and related immune-mediated diseases. Its product portfolio includes multiple investigational candidates in clinical development, reflecting a research-driven model that combines computational biology, antibody engineering, and translational science. Adagene Inc. ADR serves the healthcare and biotechnology markets by advancing differentiated therapeutic candidates aimed at complex cancers that remain difficult to treat with conventional approaches. As an ADR, the company provides investors with depositary-share exposure to its underlying business while remaining primarily identified with its biopharmaceutical operations in China.
WebsiteBuilding C14
Suzhou, 215123
China
Detailed price information for Adagene Inc ADR (ADAG-Q) from The Globe and Mail including charting and trades.
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies today announced that Third Arc Bio, Inc. (“Third Arc Bio”) selected the first lead candidate under the amended strategic licensing agreement. The agreement was est
Investors talking about ADAG also mention
What share of all stock conversation is about ADAG?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about ADAG that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 0% -100 | 9.09% -90.91 | 79.78% -20.22 | ||
| Bearish | — | 100% new | 90.91% +90.91 | 20.22% +20.22 |
Of the messages about ADAG that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 30% | 81.29% | ||
| Technical Analysis | — | 0% | 30% | 11.61% | ||
| Analysts | — | 0% | 40% | 6.45% | ||
| Controversies | — | 0% | 0% | 0% | ||
| Earnings | — | 0% | 0% | 0.65% | ||
| Macro | — | 0% | 0% | 0% |
Of the messages about ADAG, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 0% | 16% | 18.93% | ||
| Newcomers | — | 100% | 84% | 81.07% |